{"id":"https://openalex.org/W4385693179","doi":"https://doi.org/10.1159/000532021","title":"Anti-TPO IgG/Total IgE Ratio: Biomarker for Omalizumab Response Prediction in Chronic Spontaneous Urticaria","display_name":"Anti-TPO IgG/Total IgE Ratio: Biomarker for Omalizumab Response Prediction in Chronic Spontaneous Urticaria","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4385693179","doi":"https://doi.org/10.1159/000532021","pmid":"https://pubmed.ncbi.nlm.nih.gov/37557083"},"language":"en","primary_location":{"id":"doi:10.1159/000532021","doi":"https://doi.org/10.1159/000532021","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000532021","pdf_url":null,"source":{"id":"https://openalex.org/S205866209","display_name":"International Archives of Allergy and Immunology","issn_l":"1018-2438","issn":["1018-2438","1423-0097"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Archives of Allergy and Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4385693179"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069603771","display_name":"Rita Br\u00e1s","orcid":"https://orcid.org/0000-0002-3059-786X","observed_orcids":["https://orcid.org/0000-0002-3059-786X"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Rita Br\u00e1s","raw_affiliation_strings":["Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007990029","display_name":"Leonor Esteves Caldeira","orcid":"https://orcid.org/0000-0003-2347-4658","observed_orcids":["https://orcid.org/0000-0003-2347-4658"]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Leonor Esteves Caldeira","raw_affiliation_strings":["Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Bernardino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Ana Bernardino","raw_affiliation_strings":["Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030205251","display_name":"C\u00e9lia Costa","orcid":"https://orcid.org/0000-0001-8313-1505","observed_orcids":["https://orcid.org/0000-0001-8313-1505"]},"institutions":[{"id":"https://openalex.org/I141596103","display_name":"University of Lisbon","ror":"https://ror.org/01c27hj86","country_code":"PT","type":"education","lineage":["https://openalex.org/I141596103"]},{"id":"https://openalex.org/I4210114390","display_name":"Centro Hospitalar Lisboa Norte","ror":"https://ror.org/020sr6z07","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210114390","https://openalex.org/I4405255475"]},{"id":"https://openalex.org/I4210149283","display_name":"Hospital de Santa Maria","ror":"https://ror.org/05bz1tw26","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210149283"]},{"id":"https://openalex.org/I4405252521","display_name":"Centro Acad\u00e9mico de Medicina de Lisboa","ror":"https://ror.org/04z3ctv55","country_code":"PT","type":"other","lineage":["https://openalex.org/I4405252521"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"C\u00e9lia Costa","raw_affiliation_strings":["Cl\u00ednica Universit\u00e1ria de Imunoalergologia, Centro Acad\u00e9mico de Medicina de Lisboa - Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal","Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica Universit\u00e1ria de Imunoalergologia, Centro Acad\u00e9mico de Medicina de Lisboa - Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal","institution_ids":["https://openalex.org/I141596103","https://openalex.org/I4405252521"]},{"raw_affiliation_string":"Immunoallergology Department, Hospital de Santa Maria - Centro Hospitalar Universit\u00e1rio Lisboa Norte, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210114390","https://openalex.org/I4210149283"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.9394,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.97673024,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"184","issue":"9","first_page":"866","last_page":"869"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.9359999895095825},{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":0.9319999814033508},{"id":"https://openalex.org/keywords/total-serum-ige","display_name":"total IgE","score":0.9559999704360962},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.753000020980835},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.9039999842643738},{"id":"https://openalex.org/keywords/anti-thyroid-peroxidase-antibodies","display_name":"thyroid peroxidase antibodies","score":0.41499999165534973},{"id":"https://openalex.org/keywords/anti-ige-therapy","display_name":"anti-IgE therapy","score":0.48399999737739563},{"id":"https://openalex.org/keywords/angioedema","display_name":"angioedema","score":0.7210000157356262},{"id":"https://openalex.org/keywords/atopy","display_name":"atopy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/eosinophils","display_name":"eosinophils","score":0.7260000109672546},{"id":"https://openalex.org/keywords/basophils","display_name":"basophils","score":0.9129999876022339}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9520239233970642},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8365598917007446},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.7634894251823425},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5388132929801941},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5013725757598877},{"id":"https://openalex.org/C2777995640","wikidata":"https://www.wikidata.org/wiki/Q1129007","display_name":"Angioedema","level":2,"score":0.4706287384033203},{"id":"https://openalex.org/C2777697326","wikidata":"https://www.wikidata.org/wiki/Q757678","display_name":"Atopy","level":3,"score":0.4381650686264038},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4309336841106415},{"id":"https://openalex.org/C2777456892","wikidata":"https://www.wikidata.org/wiki/Q107988","display_name":"Basophil","level":4,"score":0.4261009693145752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41787290573120117},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4054737985134125},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.40208691358566284},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007073","descriptor_name":"Immunoglobulin E","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D014581","descriptor_name":"Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000532021","doi":"https://doi.org/10.1159/000532021","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000532021","pdf_url":null,"source":{"id":"https://openalex.org/S205866209","display_name":"International Archives of Allergy and Immunology","issn_l":"1018-2438","issn":["1018-2438","1423-0097"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Archives of Allergy and Immunology","raw_type":"journal-article"},{"id":"pmid:37557083","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37557083","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International archives of allergy and immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2887855058","https://openalex.org/W2898883591","https://openalex.org/W2951200598","https://openalex.org/W3154229430","https://openalex.org/W3189791963","https://openalex.org/W3200862524"],"related_works":["https://openalex.org/W4392558259","https://openalex.org/W2765477066","https://openalex.org/W4386826973","https://openalex.org/W4394840577","https://openalex.org/W4411880798","https://openalex.org/W4378839878","https://openalex.org/W4413788572","https://openalex.org/W4391535187","https://openalex.org/W7163671609","https://openalex.org/W4319082230"],"abstract_inverted_index":{"BACKGROUND:":[0],"According":[1],"to":[2,32,43,75,230,297],"recently":[3],"published":[4],"data,":[5],"low":[6,259],"total":[7,188],"IgE,":[8,92],"elevated":[9],"IgG-anti-TPO,":[10,93],"and":[11,34,68,94,111,179,193,210],"a":[12,63,291,304],"high":[13,286],"IgG-anti-TPO/total":[14,45,95,221,287],"IgE":[15,46,96,189,222,288],"ratio":[16,97,223,289],"are":[17],"good":[18,292],"biomarkers":[19,102,274],"for":[20],"subtype":[21],"IIb":[22],"autoimmune":[23,168],"chronic":[24,161],"spontaneous":[25],"urticaria":[26],"(CSU),":[27],"which":[28],"is":[29],"frequently":[30],"refractory":[31],"antihistamines":[33],"omalizumab.":[35],"OBJECTIVES:":[36],"The":[37],"aim":[38],"of":[39,56,82,127,243,267,294,312],"the":[40,78,241,258,265,310],"study":[41,55],"was":[42,224,290],"evaluate":[44],"ratio's":[47],"utility":[48],"in":[49,77,199,299],"omalizumab":[50,61,147,171,231,298],"response":[51,76,229,245,268,296],"prediction.":[52],"METHODS:":[53],"Retrospective":[54],"CSU":[57,139,301],"patients":[58],"treated":[59],"with":[60,227,254,269,303],"at":[62],"UCARE":[64],"between":[65,280],"January":[66],"2009":[67],"February":[69],"2022.":[70],"Patients":[71],"were":[72,98,114,177,191,197],"grouped":[73],"according":[74],"first":[79],"16":[80],"weeks":[81],"treatment:":[83],"responders":[84,178,202],"UAS7":[85],"<":[86,121,252],"7":[87],"versus":[88,201,282],"partial/non-responders":[89,200,281],"UAS7\u22657.":[90],"Total":[91,126],"compared.":[99],"Other":[100,272],"inflammatory":[101],"-":[103,113],"eosinophils,":[104],"basophils,":[105],"C-reactive":[106],"protein,":[107],"erythrocyte":[108],"sedimentation":[109],"rate,":[110],"d-dimer":[112],"analyzed.":[115],"STATISTICAL":[116],"ANALYSIS:":[117],"SPSS\u00ae":[118],"(v25.0),":[119],"p":[120,207,215,251],"0.05":[122],"statistically":[123],"significant.":[124],"RESULTS:":[125],"175":[128],"patients,":[129],"140":[130],"(80%)":[131],"women,":[132],"median":[133],"age":[134],"49":[135],"[9-88]":[136],"years,":[137,146],"mean":[138,187,194],"duration":[140,148],"pre-omalizumab":[141],"5.6":[142],"\u00b1":[143,150],"8.2":[144],"[0-54]":[145],"3.2":[149],"2.5":[151],"[0-12]":[152],"years.":[153],"116":[154],"(66%)":[155],"had":[156],"angioedema,":[157],"77":[158],"(44%)":[159],"inducible":[160],"urticaria,":[162],"60":[163],"(34%)":[164],"atopy,":[165],"24":[166],"(14%)":[167],"disease.":[169],"With":[170],"300":[172],"mg":[173],"q4":[174],"weeks,":[175],"69%":[176],"31%":[180],"partial/non-responders.":[181],"Although":[182],"not":[183,263,276],"reaching":[184],"significant":[185,278],"differences,":[186],"values":[190,196,270],"lower":[192],"IgG-anti-TPO":[195],"higher":[198,220],"(152":[203],"vs.":[204,212],"242":[205],"kU/L,":[206],"=":[208,216,233],"0.207,":[209],"38.3":[211],"25.7":[213],"U/mL,":[214],"0.408,":[217],"respectively).":[218],"A":[219,235,285],"significantly":[225],"associated":[226],"poorer":[228,244,313],"(p":[232],"0.040).":[234],"cut-off":[236,305],">0.154":[237,306],"increased":[238],"10":[239,308],"times":[240,309],"odd":[242,311],"[95%":[246],"CI":[247],"4.62-22],":[248],"AUC":[249],"0.872,":[250],"0.001,":[253],"87.7%":[255],"sensitivity,":[256],"although":[257],"specificity":[260],"(22.4%)":[261],"does":[262],"allow":[264],"assumption":[266],"<0.154.":[271],"laboratory":[273],"did":[275],"show":[277],"differences":[279],"responders.":[283],"CONCLUSIONS:":[284],"biomarker":[293],"poor":[295],"our":[300],"cohort,":[302],"increasing":[307],"response.":[314]},"counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":7}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-08-10T00:00:00"}